Kapan Regeneron Pharmaceuticals, Inc. nganakake statement laba lan rugi?
Laporan laba lan rugi Regeneron Pharmaceuticals, Inc. diterbitake sepisan, laporan laporan keuangan Regeneron Pharmaceuticals, Inc. paling anyar diterbitake ing 31/03/2021.
Apa keuntungan saka saham Regeneron Pharmaceuticals, Inc.?
Anggaran pangentukan per saham saka Regeneron Pharmaceuticals, Inc. ana 9.89 $ ing laporan keuangan pungkasan.
Kapan Regeneron Pharmaceuticals, Inc. bakal nerbitake statement laba lan rugi sabanjure?
Laporan sabanjure babagan akun laba lan rugi Regeneron Pharmaceuticals, Inc. bakal dadi Juni 2024.
Regeneron Pharmaceuticals, Inc. penghasilan saben saham - karakteristik finansial perusahaan babagan ukuran. Pangentukan saben saham diwilang mung - kabeh bathi perusahaan kanggo laporan keuangan sing dibagi karo jumlah saham. Cetha yen Regeneron Pharmaceuticals, Inc. penghasilan saben saham minangka karakteristik finansial kanggo sawetara wektu. Bathi saka Regeneron Pharmaceuticals, Inc. - kauntungan kabeh perusahaan ing wektu laporan.
|
Profit Regeneron Pharmaceuticals, Inc.
Bathi kanggo perusahaan kabeh Regeneron Pharmaceuticals, Inc. luwih penting kanggo ngatur manajer tinimbang para pemegang saham perusahaan. Pemegang saham luwih kasengsem ngasilake penghasilan. Babagan utama mengaruhi dividen sing ditampa ing saham. Tanggal Regeneron Pharmaceuticals, Inc. laporan bathi wis diatur dening manajemen organisasi. Tanggal Regeneron Pharmaceuticals, Inc. pernyataan bathi kanggo wektu anyar ditampilake ing tabel lan grafik layanan online.
|
Keuntungan kuartal Regeneron Pharmaceuticals, Inc.
Pangentukan saben saham Regeneron Pharmaceuticals, Inc. diitung kanthi mbagi bathi perusahaan kanthi jumlah saham. Pangentukan saben saham saka Regeneron Pharmaceuticals, Inc. ditemtokake kanggo wektu finansial tetep lan cocog karo output penyata finansial babagan bathi perusahaan. Regeneron Pharmaceuticals, Inc. penghasilan saben saham kanggo wektu paling anyar yaiku ing grafik ing kolom sisih tengen. Regeneron Pharmaceuticals, Inc. penghasilan kuartal kanggo analitis finansial minangka laporan interim utama kanggo taun finansial.
|
|
Tanggal laporan REGN
|
Pangentukan saben bareng
Pangentukan per saham diwatesi kanthi pamisahake net income (utawa laba) kanthi nomer saham perusahaan.
|
Ngganti taun %
|
|
31/03/2021 |
9.89 USD |
- |
|
31/12/2020 |
9.53 USD |
+27.07% ↑ |
|
30/09/2020 |
8.36 USD |
+25.34% ↑ |
|
30/06/2020 |
7.16 USD |
+18.94% ↑ |
|
31/12/2019 |
7.5 USD |
+23.6% ↑ |
|
30/09/2019 |
6.67 USD |
+23.9% ↑ |
|
30/06/2019 |
6.02 USD |
+15.2% ↑ |
|
31/03/2019 |
4.45 USD |
+25.67% ↑ |
|
31/12/2018 |
6.84 USD |
+23.67% ↑ |
|
30/09/2018 |
5.87 USD |
+33.36% ↑ |
|
30/06/2018 |
5.45 USD |
+48.26% ↑ |
|
31/03/2018 |
4.67 USD |
+42.19% ↑ |
|
31/12/2017 |
5.23 USD |
+49.53% ↑ |
|
30/09/2017 |
3.99 USD |
+42.21% ↑ |
|
30/06/2017 |
4.17 USD |
+19.56% ↑ |
|
31/03/2017 |
2.92 USD |
+18.6% ↑ |
|
31/12/2016 |
3.04 USD |
-10.934% ↓ |
|
30/09/2016 |
3.13 USD |
-18.0598% ↓ |
|
30/06/2016 |
2.82 USD |
-4.6082% ↓ |
|
31/03/2016 |
2.57 USD |
-3.929% ↓ |
|
31/12/2015 |
2.83 USD |
+19.27% ↑ |
|
30/09/2015 |
3.47 USD |
+24.15% ↑ |
|
30/06/2015 |
2.89 USD |
+20.76% ↑ |
|
31/03/2015 |
2.88 USD |
+21.93% ↑ |
|
31/12/2014 |
2.79 USD |
+186.59% ↑ |
|
30/09/2014 |
2.52 USD |
+184.61% ↑ |
|
30/06/2014 |
2.47 USD |
+161.62% ↑ |
|
31/03/2014 |
2.26 USD |
+124.92% ↑ |
|
31/12/2013 |
0.86 USD |
-11.887% ↓ |
|
30/09/2013 |
1.25 USD |
-4.49% ↓ |
|
30/06/2013 |
0.79 USD |
+229.25% ↑ |
|
31/03/2013 |
0.9 USD |
-525.274% ↓ |
|
31/12/2012 |
1.22 USD |
-283.005% ↓ |
|
30/09/2012 |
1.72 USD |
-224.67% ↓ |
|
30/06/2012 |
0.7 USD |
-165.249% ↓ |
|
31/03/2012 |
0.16 USD |
-35.754% ↓ |
|
31/12/2011 |
-0.54 USD |
-46.397% ↓ |
|
30/09/2011 |
-0.68 USD |
-55.541% ↓ |
|
30/06/2011 |
-0.69 USD |
-8.163% ↓ |
|
31/03/2011 |
-0.49 USD |
-27.125% ↓ |
|
31/12/2010 |
-0.17 USD |
-4.041% ↓ |
|
30/09/2010 |
-0.41 USD |
-40.356% ↓ |
|
30/06/2010 |
-0.31 USD |
-24.533% ↓ |
|
31/03/2010 |
-0.38 USD |
-37.15% ↓ |
|
31/12/2009 |
-0.46 USD |
-10.266% ↓ |
|
30/09/2009 |
-0.01 USD |
-36.693% ↓ |
|
30/06/2009 |
-0.19 USD |
-7.213% ↓ |
|
31/03/2009 |
-0.22 USD |
-4.792% ↓ |
|
31/12/2008 |
-0.4 USD |
-36.514% ↓ |
|
30/09/2008 |
-0.27 USD |
-5.0614% ↓ |
|
30/06/2008 |
-0.23 USD |
-28.793% ↓ |
|
31/03/2008 |
-0.15 USD |
-34.619% ↓ |
|
31/12/2007 |
-0.19 USD |
-6.74% ↓ |
|
30/09/2007 |
-0.54 USD |
-46.365% ↓ |
|
30/06/2007 |
-0.41 USD |
-24.189% ↓ |
|
31/03/2007 |
-0.46 USD |
-19.13% ↓ |
|
31/12/2006 |
-0.51 USD |
-22.237% ↓ |
|
30/09/2006 |
-0.48 USD |
-5.28% ↓ |
|
30/06/2006 |
-0.41 USD |
-8.85% ↓ |
|
31/03/2006 |
-0.36 USD |
-55% ↓ |
|
31/12/2005 |
-0.53 USD |
-44.648% ↓ |
|
30/09/2005 |
-0.52 USD |
-33.258% ↓ |
|
30/06/2005 |
-0.38 USD |
-41.101% ↓ |
|
31/03/2005 |
-0.07 USD |
-36.307% ↓ |
|
31/12/2004 |
0.05 USD |
-31.698% ↓ |
|
30/09/2004 |
-0.2 USD |
-24.571% ↓ |
|
30/06/2004 |
-0.26 USD |
-45.346% ↓ |
|
31/03/2004 |
1.06 USD |
-48.718% ↓ |
|
31/12/2003 |
-0.35 USD |
-37.463% ↓ |
|
30/09/2003 |
-0.52 USD |
-32.692% ↓ |
|
30/06/2003 |
-0.58 USD |
-12.941% ↓ |
|
31/03/2003 |
-0.68 USD |
-26.331% ↓ |
|
31/12/2002 |
-0.81 USD |
- |
|
30/09/2002 |
-0.75 USD |
- |
|
30/06/2002 |
-0.69 USD |
- |
|
31/03/2002 |
-0.58 USD |
- |
Regeneron Pharmaceuticals, Inc. penghasilan seprapat saben saham minangka anggaran keuntungan perusahaan. Dheweke duwe makna perantara ing antarane analis. Nanging penghasilan saben saham penting banget. Keuntungan seprapat suwene Regeneron Pharmaceuticals, Inc. saiki dianggep minangka bathi saparapat kanggo kuartal fiskal tertutup taun iki. Owah-owahan bathi saka Regeneron Pharmaceuticals, Inc. kanggo taun diwilang dibandhingake karo periode keuangan sing padha karo indikator saiki mung kanggo taun sadurunge. Owah-owahan bathi sapunika saka Regeneron Pharmaceuticals, Inc. minangka nilai sing kurang pinunjul karo owah-owahan bathi Regeneron Pharmaceuticals, Inc..
Dinamika bathi perusahaan ditampilake minangka persentase. Ing tabel layanan Keuntungan Keuntungan ing kaca iki, sampeyan bisa nemokake riwayat Regeneron Pharmaceuticals, Inc. kanggo wektu pelapor sadurunge, kanggo taun kepungkur utawa interval liyane. Regeneron Pharmaceuticals, Inc. database riwayat penghasilan seprapat katon online sajrone dekade kepungkur. Database bathi Regeneron Pharmaceuticals, Inc. perusahaan taun kepungkur diklumpukake saka sumber terbuka.
|
